Transforming the Future of Hepatology (Part 2C, Breakout Session) : Clinical Trial Design and How to Pick Your Endpoints to Answer Your Research Question

Nov 18 2024
Convention Center: Ballroom 6C
3:45 PM - 4:45 PM

Description

This 2-part workshop is dedicated to fostering innovation and collaboration in hepatology research. In part 1, invited talks led by top experts introduce attendees to forward-thinking perspectives on essential research aspects—including cohort design, biomarker development, and clinical trials—providing a rich base for informed conversations. Part 2 deepens the discussions in breakout sessions where experts and junior faculty jointly tackle practical issues of cohort development, biomarker development, and clinical trials. This workshop promises a stimulating environment for attendees to engage in robust discussions and learn from each other with the goal of driving improvements in hepatology research and, ultimately, patient outcomes.
 

Presentations

3:45 PM - 4:00 PM
Nov 18 2024
San Diego, CA

Designing Clinical Trial Endpoints and Outcomes: From Idea to Protocol Execution

Anna Lok, MD, FAASLD, Presenter
Acute Liver Failure
Acute-on-Chronic Liver Failure
ALD
4:00 PM - 4:15 PM
Nov 18 2024
San Diego, CA

Designing Clinical Trial Endpoints and Outcomes: From Idea to Protocol Execution

Alexandra T Strauss, MD, PhD, MIE, Presenter
Acute Liver Failure
Acute-on-Chronic Liver Failure
ALD

Objectives

  • Describe how to build a cohort for clinical research.
  • Identify how to leverage translational research or biomarkers to improve patient clinical outcomes in liver transplantation.
  • Review how to optimize study designs and endpoints, and overcome pitfalls in clinical trial design in portal hypertension.
Chair

Christine C Hsu, MD

National Institute of Health